Parkinson's Virtual Biotech
The Parkinson's Virtual Biotech is the drug development arm of Parkinson’s UK.
Fast tracking new treatments
Our virtual biotech fast tracks the most promising scientific discoveries to rapidly develop and test promising Parkinson's treatments.
Our Director of Research, Dr Arthur Roach, explains more about this unique approach and how it will deliver better treatments, faster.
About the Parkinson's Virtual Biotech
WHAT IS THE PARKINSON'S VIRTUAL BIOTECH?
A biotech is a company that uses the latest technology and expertise to take the best science discoveries and develop new medical treatments.
The Parkinson's Virtual Biotech works just like a regular biotech company - creating and testing new treatments for Parkinson's.
But instead of doing it for profit, we are doing it for people affected by Parkinson's.
Our mission is to invest £2-4million per year - totalling £11million by 2020 - to fast track projects to rapidly develop and test treatments with the potential to transform life for people with Parkinson's.
We are hoping to create a portfolio of projects that can attract further investment, and we’ll look to partner with companies to take successful projects into the later stages of drug development and trials.
HOW DOES IT WORK?
Unlike our traditional research grants, projects supported within the Virtual Biotech are managed and developed in partnership with Parkinson's UK.
We select and manage projects at the drug discovery, preclinical and early clinical development stages.
Our virtual approach means we can work flexibly and creatively with leading research organisations - clinical and academic institutions, pharmaceutical companies and biotechs worldwide - that can work with us in a results-focused, efficient way to develop and commercialise new treatments for Parkinson's.
HOW LONG WILL IT TAKE TO DELIVER NEW TREATMENTS?
By 2020, we want a range of new potential treatments to be advancing through our Virtual Biotech, to give us a real chance of finding a better treatments and a cure within years rather than decades.
With guidance from our panel of industry and scientific experts we are selecting projects with the greatest potential.
And like a real company, we are hands-on, managing these projects to ensure they deliver results as quickly as possible.
How is Parkinson's UK delivering new treatments faster?
Our research initiatives, like the Virtual Biotech, are speeding up every stage of the research pipeline.
We're backing the best and brightest minds to unlock new ideas and bringing the right people together to make clinical trials faster, cheaper and more likely to succeed.
We're also taking the fastest route to better treatments by tracking down drugs already approved and in use for other conditions, which have untapped potential for Parkinson's.
Work with us
We partner with organisations from around the globe to accelerate progress towards new and better treatments. Our flexible approach and in-house expertise make us the ideal partner.
Discover more about what we look for in a project by visiting the Parkinson's Virtual Biotech website.